Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

被引:35
|
作者
Mamiya, Y [1 ]
Kanazawa, H [1 ]
Kimura, Y [1 ]
Narahara, Y [1 ]
Yamate, Y [1 ]
Nakatsuka, K [1 ]
Sakamoto, C [1 ]
机构
[1] Nippon Med Coll, Dept Internal Med 3, Bunkyo Ku, Tokyo 1138603, Japan
关键词
transjugular intrahepatic portosystemic shunt; complications; hepatic encephalopathy; liver cirrhosis; portal hypertension;
D O I
10.1016/j.hepres.2004.09.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The aim of this prospective study was to investigate the incidence, clinical features and the short- and long-term clinical course of hepatic encephalopathy (HE) after transjugular intrahepatic portosysternic shunt (TIPS) in Japanese patients. Eighty-seven consecutive patients with liver cirrhosis presenting with complications of portal hypertension underwent TIPS. The mean follow-up period after TIPS was 866 days. During the follow-up, HE occurred in 52% of patients throughout the follow-up period. The cumulative incidence of postTIPS HE was 50.5 +/- 5.6% at 1 year (mean +/- S.D.). Most cases (89%) occurring within 7 days were easily controlled by the conventional therapy. Only two patients developed severe chronic HE, which was treated by reducing the shunt diameter. Older age, indication for TIPS (ascites) and higher retention rate of indocyanine green at 15 min were identified as risk factors for post-TIPS HE. During long-term follow-up, the incident of post-TIPS HE decreased among survivals. The cumulative survival rate was similar in patients with or without post-TIPS HE. Our results indicate that post-TIPS HE are a frequent complication, particularly in the early months after TIPS. However., it can be easily managed in the majority of patients. The development of post-TIPS HE is not associated with poor prognosis in TIPS patients. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 50 条
  • [21] Hepatic encephalopathy and survival after transjugular intrahepatic portosystemic shunt: Do spontaneous portosystemic shunts matter?
    Zhang, Feng
    Zhang, Ming
    Wang, Lei
    Zhuge, Yuzheng
    JOURNAL OF HEPATOLOGY, 2024, 80 (06) : e260 - e261
  • [22] Effects of different stent configurations on shunt failure and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
    李伟之
    ChinaMedicalAbstracts(InternalMedicine), 2018, 35 (01) : 42 - 43
  • [23] Combined Spontaneous Portosystemic Shunt Embolization and Transjugular Intrahepatic Portosystemic Shunt Creation for Treatment of Hepatic Encephalopathy
    Gurtatta, Rajangad S.
    Gaba, Ron C.
    Herren, Josi L.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2024, 35 (05) : 659 - 663
  • [24] Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study
    Riggio, O
    Masini, A
    Efrati, C
    Nicolao, F
    Angeloni, S
    Salvatori, FM
    Bezzi, M
    Attili, AF
    Merli, M
    JOURNAL OF HEPATOLOGY, 2005, 42 (05) : 674 - 679
  • [25] A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients
    Xiaochun Yin
    Feng Zhang
    Huiwen Guo
    Chunyan Peng
    Wei Zhang
    Jiangqiang Xiao
    Yi Wang
    Xiaoping Zou
    Ming Zhang
    Yuzheng Zhuge
    Scientific Reports, 10
  • [26] Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study
    Yang Yang
    Sirui Fu
    Bin Cao
    Kenan Hao
    Yong Li
    Jianwen Huang
    Wenfeng Shi
    Chongyang Duan
    Xiao Bai
    Kai Tang
    Shirui Yang
    Xiaofeng He
    Ligong Lu
    Hepatology International, 2021, 15 : 730 - 740
  • [27] Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study
    Yang, Yang
    Fu, Sirui
    Cao, Bin
    Hao, Kenan
    Li, Yong
    Huang, Jianwen
    Shi, Wenfeng
    Duan, Chongyang
    Bai, Xiao
    Tang, Kai
    Yang, Shirui
    He, Xiaofeng
    Lu, Ligong
    HEPATOLOGY INTERNATIONAL, 2021, 15 (03) : 730 - 740
  • [28] Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement
    Nardelli, Silvia
    Lattanzi, Barbara
    Torrisi, Sabrina
    Greco, Francesca
    Farcomeni, Alessio
    Gioia, Stefania
    Merli, Manuela
    Riggio, Oliviero
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (06) : 934 - 936
  • [29] Risk Factors for Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Beyond Stent Diameter
    Wang, Xiaoze
    Luo, Xuefeng
    Yang, Li
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (12) : 4568 - 4569
  • [30] A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients
    Yin, Xiaochun
    Zhang, Feng
    Guo, Huiwen
    Peng, Chunyan
    Zhang, Wei
    Xiao, Jiangqiang
    Wang, Yi
    Zou, Xiaoping
    Zhang, Ming
    Zhuge, Yuzheng
    SCIENTIFIC REPORTS, 2020, 10 (01)